(Fighting New Coronary Pneumonia) The U.S. Drug Administration approved the provision of Pfizer or Modena vaccine booster shots to all adults

  China News Service, Washington, November 19 (Reporter Sha Hanting) The U.S. Food and Drug Administration (FDA) approved on the 19th local time to provide Pfizer or Modena new crown vaccine booster shots to all people aged 18 and over.

  The FDA stated in the statement that all people aged 18 and above, regardless of whether they were previously vaccinated by Pfizer or Modena, can choose Pfizer or Modena booster 6 months after the second dose of vaccine. The booster brand does not need to be vaccinated with the previous vaccination. The vaccine is the same.

Data map: On November 3, local time, the National Children's Hospital vaccinated children in Washington, USA.

The new crown vaccination in the United States has entered a new phase, and millions of elementary school students can now be vaccinated.

  FDA Acting Director Woodcock said on the same day that during the new crown epidemic, the FDA has been making corresponding decisions based on the epidemic situation. Approving the booster shot for all people aged 18 and above will help strengthen the vaccine protection, especially in the prevention of severe illness.

  Pfizer said that the results of a trial of 10,000 participants showed that after the booster shot, the vaccine's effectiveness in preventing symptomatic infections can reach 95%, including the highly contagious delta mutant strain.

The side effects of the booster shot were not significantly different from the previous two doses of vaccine.

  A number of studies have shown that the effective rate of the new crown vaccine will diminish over time.

Experts believe that the benefits of enhanced needles outweigh its side effects.

  Recently, the number of new coronavirus cases in the United States has once again been on the rise.

According to statistics from the Centers for Disease Control and Prevention of the United States, the number of new cases in a single day on the 17th exceeded 100,000, and the average number of new cases per day in the past 7 days reached 88,000; the number of deaths in a single day on the 17th reached 1,301, and the number of deaths in a single day in the past 7 days The average death toll exceeds 1,000.

  Many experts said that as the weather turns colder, the increase in indoor activities and holiday trips and gatherings may lead to a rebound of the epidemic. At this time, all adults are approved to provide booster needles in the hope that the epidemic can be more effectively responded to.

(over)